perfectusbiomed品牌介绍
品牌简介
Perfectus Biomed的首席执行官Samantha Westgate博士于2012年通过Midven Rainbow Seed Fund和SPARK Northwest Fund for Biomedical的投资成立了这家公司，为抗菌剂社区设计定制的微生物服务。
2020年，Perfectus与美国实验室Extherid Biosciences LLC合并，成立Perfectus Biomed Group。Extherid的创始人Marnie Peterson博士现在是该集团的首席信息官，带来了20多年在学术界和工业界获得的专业知识。
Perfectus Biomed的使命是通过提供卓越的定制微生物服务来提高生活质量。Perfectus的全球管理团队不仅致力于与客户建立关系，还致力于与同事建立关系，以领导一支敬业、负责任的团队，为客户提供卓越的服务。该团队采用创新的方法在现实世界中取得成果，分享专业知识和知识，这是Perfectus Biomed提供服务的基础。
Perfectus Biomed’s CEO, Dr Samantha Westgate, incorporated the business in 2012, through investment from Midven Rainbow Seed Fund and SPARK Northwest Fund for Biomedical, to design customized microbiological services that serve the antimicrobial community.
In 2020 Perfectus merged with US based laboratory Extherid Biosciences LLC, forming Perfectus Biomed Group. Extherid’s founder, Dr Marnie Peterson, is now the group’s CSO bringing 20+ years of expertise gained in academia and industry.
Perfectus Biomed’s mission is to improve quality of life through the provision of exceptional, customized microbiological services. The global management team at Perfectus work towards building relationships not only with clients, but also with their colleagues, in order to lead a dedicated and accountable team that provide an exceptional service. The team take an innovative approach to achieving results in the real world, sharing expertise and knowledge that is fundamental to the services provided by Perfectus Biomed.
Main product
Microbiology Testing & Research
Biofilm Testing
Viral Testing
Molecular Testing
in vitro & ex vivo Tissue Models
Biocompatibility and Safety
SECTORS
Biocides & Disinfectants
Wound Care
Industrial Biofilms
Cosmetics & Personal Care
Infectious Diseases
Oral Care & Dentistry
Medical Devices
https://perfectusbiomed.com
联系我们
